" /> Regorafenib Anhydrous - CISMeF





Preferred Label : Regorafenib Anhydrous;

NCIt synonyms : BAY 73-4506; 4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide; Multitargeted Receptor Tyrosine Kinase Inhibitor BAY 73-4506;

NCIt related terms : Regorafenib;

NCIt definition : The anhydrous form of regorafenib, an orally bioavailable small molecule with potential antiangiogenic and antineoplastic activities. Regorafenib binds to and inhibits vascular endothelial growth factor receptors (VEGFRs) 2 and 3, and Ret, Kit, PDGFR and Raf kinases, which may result in the inhibition of tumor angiogenesis and tumor cell proliferation. VEGFRs are receptor tyrosine kinases that play important roles in tumor angiogenesis; the receptor tyrosine kinases RET, KIT, and PDGFR, and the serine/threonine-specific Raf kinase are involved in tumor cell signaling.;

UNII : 24T2A1DOYB;

InChIKey : FNHKPVJBJVTLMP-UHFFFAOYSA-N;

CAS number : 755037-03-7;

Molecule name : BAY 734506; BAY 73 4506;

Chemical formula : C21H15ClF4N4O3;

Codes from synonyms : 438;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
27/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.